Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Gynecol Oncol. 2015 May 11;138(1):62–69. doi: 10.1016/j.ygyno.2015.04.037

Table 1.

Clinical and demographic characteristics of the cohort stratified by age at surgery.

<50 years 50–59 years 60–69 years ≥70 years P-value

N (%) N (%) N (%) N (%)
547 (19.1) 784 (27.3) 838 (29.2) 701 (24.4)
Year of procedure 0.08
2005–2006 5 (0.9) 7 (0.9) 5 (0.6) 10 (1.4)
2007 8 (1.5) 23 (2.9) 22 (2.6) 25 (3.6)
2008 33 (6.0) 49 (6.3) 41 (4.9) 46 (6.6)
2009 68 (12.4) 70 (8.9) 88 (10.5) 51 (7.3)
2010 74 (13.5) 98 (12.5) 107 (12.8) 81 (11.6)
2011 166 (30.4) 241 (30.7) 251 (30.0) 221 (31.5)
2012 193 (35.3) 296 (37.8) 324 (38.7) 267 (38.1)
Race 0.0003
White 388 (70.9) 575 (73.3) 661 (78.9) 540 (77.0)
Black 52 (9.5) 56 (7.1) 37 (4.4) 45 (6.4)
Other 27 (4.9) 30 (3.8) 19 (2.3) 15 (2.1)
Unknown 80 (14.6) 123 (15.7) 121 (14.4) 101 (14.4)
BMI <0.0001
Normal 202 (36.9) 275 (35.1) 275 (32.8) 276 (39.4)
Overweight 136 (24.9) 195 (24.9) 258 (30.8) 238 (34.0)
Obese 197 (36.0) 302 (38.5) 300 (35.8) 185 (26.4)
Unknown 12 (2.2) 12 (1.5) 5 (0.6) 2 (0.3)
ASA Class <0.0001
1 43 (7.9) 33 (4.2) 15 (1.8) 3 (0.4)
2 287 (52.5) 399 (50.9) 347 (41.4) 228 (32.5)
3 204 (37.3) 330 (42.1) 440 (52.5) 433 (61.8)
≥4 12 (2.2) 21 (2.7) 36 (4.3) 37 (5.3)
Unknown 1 (0.2) 1 (0.1) 0 (0.0) 0 (0.0)
Functional status 0.02
Independent 531 (97.1) 770 (98.2) 824 (98.3) 668 (95.3)
Partially dependent 11 (2.0) 11 (1.4) 13 (1.6) 29 (4.1)
Totally dependent 4 (0.7) 3 (0.4) 1 (0.1) 4 (0.6)
Unknown 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0)
Modified frailty index
Median (IQR) 0 (0-0) 0 (0–0.09) 0.09 (0–0.2) 0.09 (0–0.2)
Preoperative albumin <0.0001
<3.5 82 (15.0) 117 (14.9) 144 (17.2) 153 (21.8)
3.5–4 120 (21.9) 179 (22.8) 220 (26.3) 207 (29.5)
>4 164 (30.0) 237 (30.2) 216 (25.8) 158 (22.5)
Unknown 181 (33.1) 251 (32.0) 258 (30.8) 183 (26.1)
Preoperative conditions
Insulin dependent diabetes mellitus 18 (3.3) 23 (2.9) 21 (2.5) 18 (2.6) <0.0001
Non-insulin dependent diabetes mellitus 18 (3.3) 43 (5.5) 82 (9.8) 86 (12.3) <0.0001
Tobacco use 116 (21.2) 131 (16.7) 103 (12.3) 48 (6.9) <0.0001
COPD 3 (0.6) 11 (1.4) 27 (3.2) 35 (5.0) <0.0001
Ascites 104 (19.0) 151 (19.3) 213 (25.4) 154 (22.0) 0.03
CHF 0 (0.0) 4 (0.5) 2 (0.2) 6 (0.9) 0.06
Hypertension 84 (15.4) 242 (30.9) 405 (48.3) 457 (65.2) <0.0001
Steroid use 11 (2.0) 19 (2.4) 30 (3.6) 28 (4.0) 0.02
Concurrent procedures
Lymphadenectomy 248 (45.3) 359 (45.8) 320 (38.2) 215 (30.7) <0.0001
Cytoreduction 224 (41.0) 371 (47.3) 458 (54.7) 351 (50.1) 0.0001
Small bowel resection 10 (1.8) 24 (3.1) 25 (3.0) 32 (4.6) 0.01
Colectomy 11 (2.0) 17 (2.2) 37 (4.4) 41 (5.9) <0.0001
Rectosigmoid resection 15 (2.7) 47 (6.0) 55 (6.6) 37 (5.3) 0.07
Hepatic resection 8 (1.5) 12 (1.5) 14 (1.7) 10 (1.4) 0.99
Bladder resection 1 (0.2) 1 (0.1) 2 (0.2) 0 (0.0) 0.52
Diaphragm resection 10 (1.8) 11 (1.4) 20 (2.4) 11 (1.6) 0.86
Extended procedure score <0.0001
0 309 (56.5) 396 (50.5) 342 (40.8) 305 (43.5)
1 201 (36.8) 300 (38.3) 394 (47.0) 319 (45.5)
2 30 (5.5) 75 (9.6) 84 (10.0) 65 (9.3)
>3 7 (1.3) 13 (1.7) 18 (2.2) 12 (1.7)